ArticleCancer research communications2023

PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.

Jack Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.